Evidence map›Paper›PMID 26539498›Full record

ArticleBioMed research international2015

The Comparative Utility of Viromer RED and Lipofectamine for Transient Gene Introduction into Glial Cells.

Sudheendra Rao, Alejo A Morales, Damien D Pearse

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Animals : an open access journal from MDPI · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Mesenchymal stem cells promote mesenteric vasodilation through hydrogen sulfide and endothelial nitric oxide.American journal of physiology. Gastrointestinal and liver physiology · 2019
    Article
  10. PMP22 Regulates Cholesterol Trafficking and ABCA1-Mediated Cholesterol Efflux.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  11. Article
  12. Review
  13. Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sudheendra RaoThe Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Alejo A MoralesThe Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Damien D PearseThe Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL 33136, USA ; The Departments of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA ; The Neuroscience Program, University of Miami Miller School of Medicine, Miami, FL 33136, USA ; The Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
University of Miami · US

Funding

Therapeutic Targeting of Intracellular Mechanisms Involved in Glial Scar FormatioR21NS077142 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PEARSE, DAMIEN D. · 2012 to 2013
$413k
NINDS NIH HHS NS077142NINDS NIH HHS R21 NS077142
6 · The paper itself

Abstract

The introduction of genes into glial cells for mechanistic studies of cell function and as a therapeutic for gene delivery is an expanding field. Though viral vector based systems do exhibit good delivery efficiency and long-term production of the transgene, the need for transient gene expression, broad and rapid gene setup methodologies, and safety concerns regarding in vivo application still incentivize research into the use of nonviral gene delivery methods. In the current study, aviral gene delivery vectors based upon cationic lipid (Lipofectamine 3000) lipoplex or polyethylenimine (Viromer RED) polyplex technologies were examined in cell lines and primary glial cells for their transfection efficiencies, gene expression levels, and toxicity. The transfection efficiencies of polyplex and lipoplex agents were found to be comparable in a limited, yet similar, transfection setting, with or without serum across a number of cell types. However, differential effects on cell-specific transgene expression and reduced viability with cargo loaded polyplex were observed. Overall, our data suggests that polyplex technology could perform comparably to the market dominant lipoplex technology in transfecting various cells lines including glial cells but also stress a need for further refinement of polyplex reagents to minimize their effects on cell viability.

Indexed as

Genetic TherapyGene Transfer TechniquesAnimalsGene ExpressionGenetic VectorsHEK293 CellsHumansLipidsNeurogliaRatsTransfectionLipidsLipofectamine

Identifiers

PMID26539498
PMCPMC4619820
OpenAlexW1921290898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.